BH3-Mimetics- and Cisplatin-Induced Cell Death Proceeds through Different Pathways Depending on the Availability of Death-Related Cellular Components

Open Access

Peer-reviewed

Research Article

Vicente Andreu-Fernández,

Affiliation Laboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, Valencia, Spain
⨯
Ainhoa Genovés,

Affiliation Laboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, Valencia, Spain
⨯
Angel Messeguer,

Affiliation Department of Chemical and Biomolecular Nanotechnology, Instituto Química Avanzada de Cataluña (CSIC), Barcelona, Spain
⨯
Mar Orzáez,

Affiliation Laboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, Valencia, Spain
⨯
Mónica Sancho,

Affiliation Laboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, Valencia, Spain
⨯
Enrique Pérez-Payá

* E-mail: eperez@cipf.es

Affiliations Laboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, Valencia, Spain, Instituto de Biomedicina de Valencia, IBV-CSIC, Valencia, Spain
⨯

Reader Comments (0)

Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Autophagic cell death
Is the Subject Area "Autophagic cell death" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Mitochondria
Is the Subject Area "Mitochondria" applicable to this article?

Thanks for your feedback.
HeLa cells
Is the Subject Area "HeLa cells" applicable to this article?

Thanks for your feedback.
Necrotic cell death
Is the Subject Area "Necrotic cell death" applicable to this article?

Thanks for your feedback.
DNA damage
Is the Subject Area "DNA damage" applicable to this article?

Thanks for your feedback.
Caspase inhibitors
Is the Subject Area "Caspase inhibitors" applicable to this article?

Thanks for your feedback.